Unmasking Undiagnosed Rare Disease Cohorts
Applying Positive-Unlabeled (PU) machine learning to fragmented claims datasets to identify high-probability patient cohorts where true negative labels do not exist.
Client: Mid-Cap Rare Disease InnovatorKnowledge Library.
Strategic analogs detailing how we isolate commercial bottlenecks, apply deterministic analytical methodologies, and mandate executive action across the life sciences ecosystem.
Temporal Trajectory Modeling for Pre-Symptomatic Intervention
Utilizing sequence-based machine learning on longitudinal Rx/Dx telemetry to predict disease progression 6-12 months before standard clinical diagnosis.
Client: Top 10 Global Neurology LeaderMapping Multi-Tier Influence Ecosystems in Oncology
Deconvoluting regional patient hand-offs and applying graph analytics to locate hidden community prescriber influence sinks driving biologic uptake.
Client: Global Tier-1 Pharma
Bayesian Trajectory Forecasting & Month 3 Course Correction
Integrating sub-national P&T formulary approvals and HCP trial-decay logic to predict launch stall curves, enabling decisive resource reallocation at Week 12.
Client: Top 5 Immunology Innovator
Causal Machine Learning for Omnichannel Optimization
Moving beyond naive deciling by estimating heterogeneous treatment effects to direct expensive rep visits exclusively to persuadable targets.
Client: Cardio-Metabolic Franchise
Tracing Patient Attrition in Specialty Biomarker Testing
Constructing a deterministic journey waterfall to pinpoint the exact days where diagnosed patients abandon treatment due to administrative friction.
Client: Precision Oncology Biotech
Dynamic Asset Valuation in Autoimmune Pipeline
Deploying stochastic market simulation to evaluate Phase II assets against future standard-of-care shifts, averting a $400M sunk-cost commitment.
Client: Mid-Cap Autoimmune Developer
Deconstructing Gross-to-Net Leakage in Competitive Immunology
Implementing contract-level profit mapping to renegotiate major PBM tiers, improving net margins by 12% in a high-rebate environment.
Client: Global Pharma Enterprise
Accelerating Peak Year Sales in Cell & Gene Therapy
Utilizing process mining on site certification logs to cut clinical onboarding times by 50%, allowing the manufacturer to reach peak capacity two years ahead of forecast.
Client: Top 3 CAR-T Manufacturer
